Search

Author/Creator Agerbaek, Mads

3. Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial. Issue 12 (December 2020)

Authors:
Powles, Thomas; van der Heijden, Michiel S; Castellano, Daniel; Galsky, Matthew D; Loriot, Yohann; Petrylak, Daniel P; Ogawa, Osamu; Park, Se Hoon; Lee, Jae-Lyun; De Giorgi, Ugo; Bögemann, Martin; Bamias, Aristotelis; Eigl, Bernhard J; Gurney, Howard; Mukherjee, Som D; Fradet, Yves; Skoneczna, Iw...
Journal:
Lancet oncology
Issue:
Volume 21:Issue 12(2020)
Page Start:
1574
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. GCT-65. INCIDENCE AND OUTCOME OF INTRACRANIAL MALIGNANT GERM CELL TUMOURS DIAGNOSED IN WESTERN DENMARK IN THE LAST DECADE. (4th December 2020)

Authors:
Lassen-Ramshad, Yasmin; Mikkelsen, Torben Stamm; Rosthoej, Steen; Henriksen, Louise Tram; Tuckuvienne, Ruta; Kristensen, Ines Ackerl; von Oettingen, Gorm; Cortnum, Soeren; Als, Anne-Birgitte; Safwat, Akmal; Agerbaek, Mads
Journal:
Neuro-oncology
Issue:
Volume 22(2020)Supplement 3
Page Start:
iii341
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3–pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial. Issue 1 (January 2015)

Authors:
Sternberg, Cora N; Skoneczna, Iwona; Kerst, J Martijn; Albers, Peter; Fossa, Sophie D; Agerbaek, Mads; Dumez, Herlinde; de Santis, Maria; Théodore, Christine; Leahy, Michael G; Chester, John D; Verbaeys, Antony; Daugaard, Gedske; Wood, Lori; Witjes, J Alfred; de Wit, Ronald; Geoffrois, Lionel; Se...
Journal:
Lancet oncology
Issue:
Volume 16:Issue 1(2015:Jan.)
Page Start:
76
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3–pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial. Issue 1 (January 2015)

Authors:
Sternberg, Cora N; Skoneczna, Iwona; Kerst, J Martijn; Albers, Peter; Fossa, Sophie D; Agerbaek, Mads; Dumez, Herlinde; de Santis, Maria; Théodore, Christine; Leahy, Michael G; Chester, John D; Verbaeys, Antony; Daugaard, Gedske; Wood, Lori; Witjes, J Alfred; de Wit, Ronald; Geoffrois, Lionel; Se...
Journal:
Lancet oncology
Issue:
Volume 16:Issue 1(2015:Jan.)
Page Start:
76
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. PD10-01 DISEASE-FREE SURVIVAL WITH LONGER FOLLOW-UP FROM THE CHECKMATE 274 TRIAL OF ADJUVANT NIVOLUMAB IN PATIENTS AFTER SURGERY FOR HIGH-RISK MUSCLE-INVASIVE UROTHELIAL CARCINOMA. (May 2022)

Authors:
Galsky, Matthew; Witjes, Johannes Alfred; Gschwend, Jürgen E.; Schenker, Michael; Valderrama, Begoña P.; Tomita, Yoshihiko; Bamias, Aristotelis; Lebret, Thierry; Shariat, Shahrokh F.; Park, Se Hoon; Agerbaek, Mads; Jha, Gautam; Stenner, Frank Stenner; Collette, Sandra; Unsal-Kacmaz, Keziban; Nasr...
Journal:
Journal of urology
Issue:
Volume 207(2022)Supplement 5
Page Start:
e183
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗